Error loading player: No playable sources found

Turning Mandates into Momentum: How CASSS Can Help Sonia Vallabh?

Date
January 30, 2025
This product is not available for individual purchase, but it is available as part of the following products:

As a follow-up to Tuesday's very impactful Keynote presentation, join us in-person or online as we come together as a community and brainstorm ways to further Sonia's mission to prevent prion disease.    


Related Products

Thumbnail for Parallel Session 2A - Science vs the Fear Factor: Alternative Potency Assays for Recombinant Biologics and Vaccines
Parallel Session 2A - Science vs the Fear Factor: Alternative Potency Assays for Recombinant Biologics and Vaccines
Potency analytical control strategies are critical to support biopharmaceutical drug and vaccine development throughout the product lifecycle…
Thumbnail for Parallel Session 5A - Integrated Control Strategy for Combination Products
Parallel Session 5A - Integrated Control Strategy for Combination Products
Drug-device combination products such as prefilled syringes, autoinjectors, etc. can play an important role to ensure patient convenience, compliance, and enhance therapeutic impact of the drug…
Thumbnail for Parallel Session 5B - Immunogenicity Risk and Control
Parallel Session 5B - Immunogenicity Risk and Control
Peptides, proteins and oligonucleotide are becoming essential medical treatments for many progressive, debilitating, or life-threatening diseases. However, the development of these potential therapies can be derailed by product immunogenicity as it can impact on safety and efficacy…